Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, fondata nel 1982. In collaborazione con l'Associazione Culturale Pediatri.
Login Abbonamenti Pubblicazioni Carrello Registrazione Perché registrarsi? Contatti

Farmacoriflessioni

Uso di antibiotici in Pediatria

Antibiotici use in paediatrics

Simona Di Mario1, Carlo Gaglioffi2, Rossella Buttazzi2, Luca Cisbani3, Antonio Brambilla1, Maria Luisa Moro2

1Servizio Assistenza Territoriale, DG Cura della Persona, Salute e Welfare, 2Agenzia Sanitaria e Sociale Regionale, 3Servizio Strutture, Tecnologie e Sistemi Informativi, DG Cura della Persona, Salute e Welfare, Regione Emilia-Romagna, Bologna

“Progetto ProBA 2014”*
*Stefano Alboresi, Sergio Amarri, Mara Asciano, Filippo Bernardi, Vincenzo Calabrese, Sergio Capobianco, Tiziano Dall’Osso, Chiara Di Girolamo, Simona Di Mario, Icilio Dodi, Alfredo Ferrari, Sara Forti, Carlo Gagliotti, Giuseppe Gregori, Massimo Magnani, Federico Marchetti, Franco Mazzini, Maria Luisa Moro, Maria Grazia Pascucci, Lamberto Reggiani, Domenico Saggese, Anna Tomesani

Novembre 2017 - pagg. 578 -583

Abstract
Inappropriate antibiotic use in paediatric care is a main issue in Italy where prescription rates are among the highest in Europe and wide spectrum antibiotics (e.g. the association amoxicillin + clavulanic acid) are the most prescribed with an increased risk of antibiotic resistance. This paper summarizes the activities and the achievements of the ProBA (Progetto Bambini e Antibiotici), a long-lasting project of the Emilia-Romagna Region (Italy) going on for more than 10 years, which aims at the containment of antibiotic overuse in children. The ProBA is focused on two leading causes of ambulatory visits and antibiotic prescriptions in paediatric primary care (i.e. acute otitis media and sore throat) and consists of the following activities: producing evidence based regional guidelines, developing and disseminating tools for the implementation of the recommendations, monitoring prescription rates and compliance to recommendations, providing regular feedback to family paediatricians and conducting regional information campaign for the general public to promote the correct use of antibiotics. The ProBA is producing a substantial decrease in the antibiotic prescription rates (from 1,277 prescriptions per 1,000 children in 2008 to 881 prescriptions per 1,000 children in 2016) coupled with a relative growth (compared with other antibiotics) of the use of amoxicillin, the first-choice antibiotic for treatment of acute otitis media and streptococcal pharyngitis. Namely, the ratio of amoxicillin versus the association amoxicillin + clavulanic acid has increased from 0.8 in 2008 to 1.1 in 2016. A further evolution of the ProBA is to cross the Emilia-Romagna borders and promote a working-together approach to produce a common set of indicators with the other Italian regions for monitoring antibiotic appropriateness in paediatric care. This could be useful to compare attitude and practice and to define joint objectives of improvement.
Contenuto riservato

Per leggere l'articolo completo è necessario effettuare il login.

Non sei ancora registrato? Registrati

Bibliografia

1. European antibiotic awareness day. http://antibiotic. ecdc.europa.eu/en/EAAD/Pages/Home. aspx. 2. World Antibiotic Awareness Week, 13-19 November 2017. http://www.who.int/campaigns/ world-antibiotic-awareness-week/en/. 3. World Health Organization. Antimicrobial resistance: global report on surveillance. Printed in France. Reprinted June 2014 with changes. http://apps.who.int/iris/bitstream/10665/11264 2/1/9789241564748_eng.pdf?ua=1. 4. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2014. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2015. https: //ecdc.europa.eu/sites/portal/files/media/en/p ublications/Publications/antimicrobial-resistance- europe-2014.pdf. 5. European Centre for Disease Prevention and Control. Summary of the latest data on antibiotic consumption in the European Union ESAC Net surveillance data. Stockholm November 2016 https://ecdc.europa.eu/sites/portal/files/documents/ antibiotics-ESAC-Net%20Summary% 202016_0.pdf. 6. Moro ML, Resi D, Morri M, et al. Prescrizione di antibiotici in etŕ pediatrica nella Regione Emilia- Romagna. Medico e Bambino pagine elettroniche 2002;5(4). 7. Gagliotti C, Buttazzi R, Moro ML, Di Mario S. Uso di antibiotici e resistenze antimicrobiche in etŕ pediatrica. Rapporto Emilia-Romagna 2016. Bologna 2017. http://assr.regione.emilia-romagna. it/it/servizi/pubblicazioni/rapporti-documenti/ antibiotici-pediatria-2016. 8. Milandri M, Marchi M, Resi D, Moro ML. Dossier n. 115/2005 - ProBA Progetto Bambini e antibiotici. I determinanti della prescrizione nelle infezioni delle alte vie respiratorie. Bologna 2005. http://assr.regione.emilia-romagna.it/it/servizi/ pubblicazioni/dossier/doss115 9. Arnold SR, Straus SE. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev 2005;(4): CD003539. 10. Vervloet M, Meulepas MA, Cals JW, Eimers M, van der Hoek LS, van Dijk L. Reducing antibiotic prescriptions for respiratory tract infections in family practice: results of a cluster randomized controlled trial evaluating a multifaceted peergroup- based intervention. NPJ Prim Care Respir Med 2016;26:15083. 11. Regev-Yochay G, Raz M, Dagan R, et al. Reduction in antibiotic use following a cluster randomized controlled multifaceted intervention: the Israeli judicious antibiotic prescription study. Clin Infect Dis 2011;53(1):33-41. 12. Di Mario S, Gagliotti C, Asciano M, et al. Dossier n. 153/2007. Faringotonsillite in etŕ pediatrica. Linea guida regionale. http://assr.regione. emilia-romagna.it/it/servizi/pubblicazioni/ dossier/doss153. 13. Di Mario S, Gagliotti C, Asciano M, et al. Dossier n. 154/2007. Otite media acuta in etŕ pediatrica. Linea guida regionale. http://assr.regione. emilia-romagna.it/it/servizi/pubblicazioni/ dossier/doss154. 14. Di Mario S, Gagliotti C, Asciano M, Moro ML, per il Comitato Tecnico Scientifico Regionale dei Pediatri “Progetto ProBA - II Fase”. La faringotonsillite e l’otite media acuta in etŕ pediatrica. La guida rapida sviluppata dalla Regione Emilia-Romagna. Medico e Bambino 2008;27(1):38-42. 15. Di Mario S, Gagliotti C, Moro ML, a nome del gruppo ProBA. La faringotonsillite in etŕ pediatrica. Aggiornamento delle linee guida della Regione Emilia-Romagna. Medico e Bambino 2015; 34(7):442-4. 16. Di Mario S, Gagliotti C, Moro ML, a nome del gruppo ProBA. Otite media acuta in etŕ pediatrica. Aggiornamento della linea guida della Regione Emilia-Romagna. Medico e Bambino 2016; 35(1):35-40. 17. Gagliotti C, Buttazzi R, Nobilio L, Tomesani A, Alboresi S, Moro ML. Uso di antibiotici e resistenze antibiotiche nella popolazione pediatrica dell’Emilia- Romagna. Bologna 2006 http://assr. regione. emilia-romagna.it/it/servizi /pubblicazioni/ rapporti-documenti/uso-antibiotici-popolazione-pediatrica- 2006. 18. Holstiege J, Schink T, Molokhia M, et al. Systemic antibiotic prescribing to paediatric outpatients in 5 European countries: a population-based cohort study. BMC Pediatr 2014;14:174. 19. Youngster I, Avorn J, Belleudi V, et al. Antibiotic use in children - A cross-national analysis of 6 Countries. J Pediatr 2017;182:239-244.e1. 20. de Bie S, Kaguelidou F, Verhamme KM, et al.; ARPEC study. Using prescription patterns in Primary Care to derive new quality indicators for childhood community antibiotic prescribing. Pediatr Infect Dis J 2016;35(12):1317-23. 21. Osservatorio Nazionale sull’impiego dei Medicinali. L’uso dei farmaci in Italia. Rapporto Nazionale 2016. Roma: Agenzia Italiana del Farmaco, 2017. 22. Piovani D, Clavenna A, Cartabia M, Bonati M; Antibiotic Collaborative Group. The regional profile of antibiotic prescriptions in Italian outpatient children. Eur J Clin Pharmacol 2012;68(6):997- 1005. 23. Gagliotti C, Buttazzi R, Di Mario S, Morsillo F, Moro ML. A region wide intervention to promote appropriate antibiotic use in children reversed trends in erythromycin resistance to Streptococcus pyogenes. Acta Paediatr 2015;104 (9):e422-4. 24. Manzotti R, Montanari R, Giorgi Rossi R, Mancuso P, Pinotti M. Linee guida e antibiotici: un’esperienza territoriale di miglioramento a Reggio Emilia. Medico e Bambino 2017;36(4):229-36.

Corrispondenza: simona.dimario@regione.emilia-romagna.it